Israeli biotech Prolor reported positive pre-clinical trial results of its long-acting anti-obesity drug candidate oxyntomodulin.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000652430&fid=1725
Meanwhile
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.